VIVO Cannabis Inc. is a Canadian licensed producer of medical and recreational cannabis products headquartered in Napanee, Ontario. The company cultivates cannabis at its 300,000-square-foot indoor facility, where it manages the cultivation, processing and packaging of dried flower, pre-rolled joints and cannabis oils. VIVO holds licenses from Health Canada for cultivation, processing and sale, positioning it to serve both domestic medical patients and the adult-use recreational market.
Since its original public listing as ABcann Global in 2015, the company has focused on building capacity and streamlining its supply chain. In early 2019, ABcann Global rebranded as VIVO Cannabis to unify its product offerings under a single consumer-friendly brand. VIVO’s portfolio includes the MÜV and SYN branded lines, emphasizing quality and consistency across flower, vape cartridges and oral formulations. The company has also invested in research and development to introduce new formats such as soft gels and fast-acting sublinguals.
In addition to its core facility in Napanee, VIVO has pursued international market access through Good Manufacturing Practice (GMP) certification, enabling potential exports to select European markets. The company has explored strategic partnerships and joint ventures to expand its distribution footprint, notably targeting emerging opportunities in Germany and other regulated jurisdictions. Domestically, VIVO leverages both wholesale agreements and direct supply arrangements with provincial retailers.
Leadership at VIVO Cannabis is anchored by Chief Executive Officer Charles Pedlar, who brings extensive experience from the Canadian licensed producer sector, alongside a management team with backgrounds in agriculture, pharmaceuticals and consumer packaged goods. Under this leadership, VIVO continues to prioritize operational efficiency, product innovation and regulatory compliance as it advances its strategy within Canada’s evolving cannabis industry.
AI Generated. May Contain Errors.